DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Garner AP, Gozgit JM, Anjum R et al.
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.
Clin Cancer Res 2014;
20: 5745-5755
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.